End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4,410 KRW | +1.38% | +2.56% | -25.38% |
2023 | Dx&Vx Co-Develops Bio-Healthcare Big Data Platform with LG CNS | CI |
2023 | Dx & Vx Co., Ltd. completed the acquisition of Avixgen, Inc. from a group of sellers | CI |
Sales 2022 | 32.18B 23.24M 31.99M | Sales 2023 | 46.75B 33.75M 46.46M | Capitalization | 179B 129M 178M |
---|---|---|---|---|---|
Net income 2022 | -780M -563K -775K | Net income 2023 | -27.48B -19.84M -27.32M | EV / Sales 2022 | 7.17 x |
Net Debt 2022 | 8.61B 6.22M 8.56M | Net Debt 2023 | 27.25B 19.67M 27.09M | EV / Sales 2023 | 4.4 x |
P/E ratio 2022 |
-285
x | P/E ratio 2023 |
-6.36
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 73.61% |
1 day | +1.38% | ||
1 week | +2.56% | ||
Current month | -11.71% | ||
1 month | -11.71% | ||
3 months | -16.95% | ||
6 months | -26.01% | ||
Current year | -25.38% |
Managers | Title | Age | Since |
---|---|---|---|
Lee Yong-Gu
CEO | Chief Executive Officer | - | 23-05-15 |
Gyu-Chan Kwon
PSD | President | 54 | 23-05-15 |
Gang-Pyeong Lee
DFI | Director of Finance/CFO | 55 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Do-Soon Hwang
BRD | Director/Board Member | 61 | - |
Wang-Jun Lee
CTO | Chief Tech/Sci/R&D Officer | 59 | 17-12-12 |
Baek-Seung Lee
CTO | Chief Tech/Sci/R&D Officer | 54 | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-30 | 4,410 | +1.38% | 69,856 |
24-04-29 | 4,350 | +0.12% | 30,372 |
24-04-26 | 4,345 | -0.23% | 27,419 |
24-04-25 | 4,355 | +1.04% | 44,820 |
24-04-24 | 4,310 | +1.17% | 63,406 |
End-of-day quote Korea S.E., April 29, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-25.38% | 96.29M | |
-18.88% | 10.91B | |
+53.75% | 3.3B | |
-32.50% | 2.19B | |
-14.31% | 2.16B | |
-26.83% | 1.5B | |
+28.55% | 1.09B | |
-3.28% | 737M | |
-23.50% | 404M | |
-43.27% | 386M |
- Stock Market
- Equities
- A180400 Stock